Stock Events

Stock Events

Design Therapeutics (DSGN) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.41

-0.34

-0.27

-0.2

Details

Expected EPS

-0.263333

Actual EPS

-0.2

Surprise EPS

0.06

Surprise Percent

+24.05%

Description

Design Therapeutics (DSGN) has reported earnings of -0.2 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.